Stock Market Reviews

Read and share opinions on WALD (Waldencast plc) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities
  Nov 14, 2025
• Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates
  Nov 12, 2025
• Why BeautyHealth (SKIN) Stock Is Trading Lower Today
  Sep 10, 2025
• Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
  Sep 10, 2025
• Waldencast price target lowered to $3 from $4 at Telsey Advisory
  Aug 21, 2025
• Waldencast plc (WALD) Acquired Novaestiq Corp. and the US Rights to the Saypha Line of Hyaluronic Acid Injectable Gels
  Aug 11, 2025
• Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast
  Jul 23, 2025
• Obagi, Milk Makeup Owner Waldencast Enters Filler Market With New Acquisition
  Jul 23, 2025
• Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
  Jul 23, 2025
• Insiders with their considerable ownership were the key benefactors as Waldencast plc (NASDAQ:WALD) touches US$290m market cap
  Jun 26, 2025
• Waldencast price target lowered to $4 from $5 at Telsey Advisory
  May 16, 2025
• Waldencast Sees Improvement of 10 bps in Adjusted Gross Margin
  May 13, 2025
• Waldencast Reports Q1 2025 Financial Results
  May 13, 2025
• Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast
  May 6, 2025
• Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream
  Apr 22, 2025
• Waldencast Full Year 2024 Earnings: EPS Misses Expectations
  Mar 22, 2025
• Waldencast PLC (WALD) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
  Mar 20, 2025